The central hypothesis of this study postulated that the inflammatory response observed in COVID-19 patients may contribute to endothelial dysfunction by means of upregulated, redox-sensitive SGLT-2 expression. This evidence concerns the gene SLC5A2 and endothelial dysfunction.